The new EU regulation introduces Joint Clinical Assessments that will run in parallel with EMA approvals, delivering comparative effectiveness data within one month of market authorisation.
Medscape News UK
Source link : https://www.medscape.com/viewarticle/esmo-2025-eu-reform-aims-fast-track-cancer-drug-access-2025a1000uqo?src=rss
Author :
Publish date : 2025-11-06 22:25:00
Copyright for syndicated content belongs to the linked Source.
